Article Details

Trillium Therapeutics (NASDAQ:TRIL) Rating Reiterated by Cowen

Retrieved on: 2019-09-06 07:15:00

Tags for this article:

Click the tags to see associated articles and topics

Trillium Therapeutics (NASDAQ:TRIL) Rating Reiterated by Cowen. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP bought a new position in Trillium Therapeutics during the 4th quarter worth $35,000. Jane Street Group LLC bought a new ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up